Shire using Baxalta network to bring 30% Cinryze production in-house
Shire has begun adding capability within its own network to manufacture the Hereditary Angioedema (HAE) product Cinryze, currently being made by Dutch CMO Sanquin.
Archives for May 4, 2017
Catalent: biologics contracting still major growth driver in Q3
Biologics contracting drove growth in fiscal Q3 according to Catalent, which predicted the proportion of revenue it generates from large molecule work will continue to increase.